Voice Of AnalystsMPS IIIA Gene Therapy, ABO-102, Shows Efficacy in Trial UpdateRare Disease ReportThis morning, Abeona Therapeutics Inc. released positive data from its phase 1/2 trial for ABO-102 (AAV-SGSH), a clinical gene therapy for the treatment o… Continue reading
Voice Of AnalystsMPS IIIA Gene Therapy, ABO-102, Shows Efficacy in Trial UpdateRare Disease ReportThis morning, Abeona Therapeutics Inc. released positive data from its phase 1/2 trial for ABO-102 (AAV-SGSH), a clinical gene therapy for the treatment o… Continue reading
Pain News NetworkTV Host Tries Stem Cell Therapy for Chronic Back PainPain News NetworkWhen he recently injured his back again and could “barely walk,” El Moussa decided stem cell therapy was a better option. In one photo of the stem cell procedure, El… Continue reading
Gene Therapy in Rare Diseases: Home and Dosing Site ConsiderationsApplied Clinical Trials Online (press release) (blog)With the rise in gene therapies entering clinical trials, it is important to address the operational challenges associated with these… Continue reading
Gene Therapy in Rare Diseases: Home and Dosing Site ConsiderationsApplied Clinical Trials Online (press release) (blog)With the rise in gene therapies entering clinical trials, it is important to address the operational challenges associated with these… Continue reading
MSUTodayGene therapy that restores vision in dogs may help humans, tooMSUTodayA Michigan State University veterinary ophthalmologist has modified a gene therapy that reverses blindness in dogs that have a certain form of a disease known as progressive … Continue reading
Myeloma Research News |
Update on bb2121, Potential Advanced Multiple Myeloma Therapy, Set for ASCO 2018
Myeloma Research News Celgene’s investigational and second-generation CAR T-cell therapy bb2121 is showing real promise in treating advanced multiple myeloma patients, those with relapsed or refractory disease, updated Phase 1 data is expected to show. An earlier analsyis … |